Ansys Inc (ANSS) concluded trading on Wednesday at a closing price of $374.3, with 18.84 million shares of worth about $7.05 billion changed hands on the day. Half year performance of the stock remained positive as price took a surge of 11.01% during that period and on July 16, 2025 the price saw a loss of about -4.69%. Currently the company’s common shares owned by public are about 87.91M shares, out of which, 87.55M shares are available for trading.
Stock saw a price change of 2.03% in past 5 days and over the past one month there was a price change of 10.74%. Year-to-date (YTD), ANSS shares are showing a performance of 13.64% which increased to 10.96% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $275.06 but also hit the highest price of $395.48 during that period. The average intraday trading volume for Ansys Inc shares is 802.40K. The stock is currently trading 4.88% above its 20-day simple moving average (SMA20), while that difference is up 8.16% for SMA50 and it goes to 11.84% higher than SMA200.
Ansys Inc (NASDAQ: ANSS) currently have 87.91M outstanding shares and institutions hold larger chunk of about 90.87% of that.
The stock has a current market capitalization of $32.91B and its 3Y-monthly beta is at 1.18. PE ratio of stock for trailing 12 months is 55.57, while it has posted earnings per share of $6.74 in the same period. Its PEG reads 7.95 and has Quick Ratio of 3.66 while making debt-to-equity ratio of 0.14. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ANSS, volatility over the week remained 3.15% while standing at 1.93% over the month.
Stock’s fiscal year EPS is expected to rise by 5.32% while it is estimated to increase by 11.04% in next year. EPS is likely to grow at an annualized rate of 6.99% for next 5-years, compared to annual growth of 4.51% made by the stock over the past 5-years.
Coverage by BofA Securities stated Ansys Inc (ANSS) stock as an Underperform in their note to investors on November 14, 2023, suggesting a price target of $295 for the stock. On December 14, 2022, Robert W. Baird Upgrade their recommendations, while on October 24, 2022, Rosenblatt Upgrade their ratings for the stock with a price target of $270. Stock get an Overweight rating from JP Morgan on September 16, 2022.
